Skip to main content
. 2018 Jul 25;9:1690. doi: 10.3389/fimmu.2018.01690

Table 1.

Dog characterization accordingly to gender, weight, age, breed, clinical classification, serological response to Leishmania, parasite isolation, and detection by quantitative polymerase chain reaction (qPCR).

Dogs Gender Weight (kg) Age (months) Breeds Clinical classification (score) Serology (DPP-LVC)® Leishmania infantum isolation + qPCR [bone marrow (BM)]
Leish-Tec® (n = 12) 6 males 18–50 11–66 4 Shepherd Malinois Low T0 = 0/12 T0 = 0/12
6 females 3 German Shepherds (0) n = 12 T1 = 0/12
4 Rottweilers T6 = 1/12a
1 Labrador T12 = 0/12

CVL (n = 10) 7 males 5–15 24–192 8 mixed breeds Low Serology (DPP-LVC® and EIE-CL) 10/10
3 females 1 Poodle (1) n = 1 10/10
1 Dachshund Moderate
(4) n = 1
High
(7) n = 2
(8) n = 1
(9) n = 4
(11) n = 1

ACVL (n = 10) 7 males 5–25 12–84 9 mixed breeds Low 10/10 9/10
3 females 1 Labrador (0) n = 9
(1) n = 1

aOne dog immunized with Leish-Tec® presented positive DPP-LVC® 6 months after vaccination although the EIE test was negative. Parasitological culture and qPCR were performed with BM and blood samples collected at the same time point and the results were negative. 1 year after immunization (T12), this dog tested negative in the DPP-LVC®. All dogs from CVL and ACVL groups presented positive DPP-LVC® and EIE tests.

Leish-Tec®—vaccinated dogs, CVL – canine visceral leishmaniasis, ACVL – asymptomatic canine visceral leishmaniasis.